Following an ace assassin who is double crossed by gangsters and falls into the hands of rogue surgeon known as The Doctor who turns him into a woman. The hitman now a hitwoman sets out for revenge.
||April 7th, 2017 (Limited) by Saban Films|
||June 6th, 2017 by Lionsgate Home Entertainment|
||R for graphic nudity, violence, sexuality, language and drug use.|
(Rating bulletin 2455 (Cert #2455), 12/14/2016)
||Create your own comparison chart…|
||Revenge, Medical Crimes, Doctors, Hitmen, Early / Simultaneous Video on Demand release|
|Production Method:||Live Action|
|Creative Type:||Contemporary Fiction|
June 6th, 2017
Summer is usually the slowest time of the year on the home market; however, this week we have the biggest theatrical hit of the year so far coming out. Unfortunately, Beauty and the Beast isn’t really Pick of the Week material. It’s not bad and the DVD or Blu-ray Combo Pack hav enough extras to be worth picking up, but that’s not enough to put it over the top. Unfortunately, the film was such a massive hit at the box office that it scared away all of the competition and there’s no real Pick of the Week films on this week’s list.
April 7th, 2017
It is a busy week for limited releases with more than a dozen titles on this week’s list. This includes a quartet of releases with good reviews and loud buzz. Gifted’s reviews are good, but likely not good enough for limited release. That said, it has a shot at becoming a sleeper hit. Their Finest is a stellar British World War II dramedy, but the cast is more famous in the U.K. than here. Your Name is arguably the best film on this week’s list and it is a monster hit worldwide. However, it is playing in over 300 theaters and that might turn out to be too many. This leaves Colossal as the film with the best shot at mainstream success. Its reviews are not the best, but the combination of reviews, cast, buzz, and commercial viability is.
Full financial estimates for this film, including domestic and international box office, video sales, video rentals, TV and ancillary revenue
are available through our research services. For more information, please contact us at email@example.com.